StocksEditas Medicine IncEDIT

EDIT

Editas Medicine Inc

9.96 -0.92 (-8.45%)
NASDAQin hinnat viiveellä, USD:na Markkinat auki
KÄY KAUPPAA
M
9.96
O
10.01
Parhaat
Fabian Hermans
$EDIT (Editas Medicine Inc) Editas provided some updates on the company during its Q1 2022 earnings release this month. Highlights include: Editas Medicine has dosed the first pediatric patient in the EDIT-101 clinical trial. The company expects to complete dosing of the mid-dose pediatric cohort in... Näytä enemmän Käännä
EDIT
Editas Medicine Inc
9.96
-0.92 (-8.45%)
KÄY KAUPPAA
MarketUpdates
$EDIT (Editas Medicine Inc) K2 2022 tulosraportin julkaisua odotetaan
3
ELO
RAPORTIT
Editas Medicine Inc K2 2022 tulosraportin julkaisun odotetaan tapahtuvan ennen markkinoiden avautumista
Ilmoita
EDIT
EDIT
Editas Medicine Inc
9.96
-0.92
(-8.45%)
KÄY KAUPPAA
MarketUpdates
$EDIT (Editas Medicine Inc) Q2 2022 earnings report is expected to be released Käännä
David Leslie
Cosmin Gheorghe Cosma
After Hours Losers $ETSY (Etsy Inc) -12.6% $EBAY (eBay) -6.6% $FSLY (Fastly Inc) -6.2% $W (Wayfair Inc.) -5.5% $EDIT (Editas Medicine Inc) -4.8% Käännä